ABCG2 p.Thr402Arg

[switch to full view]
Comments [show]
Publications
PMID: 20088606 [PubMed] Polgar O et al: "Mutational analysis of threonine 402 adjacent to the GXXXG dimerization motif in transmembrane segment 1 of ABCG2."
No. Sentence Comment
4 Single mutations to leucine (T402L) or arginine (T402R) did not have a significant impact on the ABCG2 protein.
X
ABCG2 p.Thr402Arg 20088606:4:49
status: VERIFIED
Login to comment

5 On the other hand, combining the T402 mutations with the GXXXG glycine to leucine mutations (T402L/ G406L/G410L and T402R/G406L/G410L) resulted in a substantially reduced level of expression, altered glycosylation, degradation by a proteosome-independent pathway, and partial retention in the endoplasmic reticulum as suggested by immunostaining, Endo H sensitivity, and MG132 and bafilomycin failed effect.
X
ABCG2 p.Thr402Arg 20088606:5:116
status: VERIFIED
Login to comment

7 The T402R/G406L/G410L mutant carrying the more drastic substitution was found to primarily localize intracellularly.
X
ABCG2 p.Thr402Arg 20088606:7:4
status: VERIFIED
Login to comment

45 The T402L, T402R, T402L/ G406L/G410L, and T402R/G406L/G410L mutants were generated by site-directed mutagenesis in the pcDNA3.1/Myc-HisA(-) vector (Invitrogen) as previously described (19).
X
ABCG2 p.Thr402Arg 20088606:45:11
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:45:42
status: VERIFIED
Login to comment

92 To study the potential role of this threonine in ABCG2 dimerization, we performed substitutions with a leucine (T402L) or arginine (T402R) substitution or combined these substitutions with the glycine to leucine mutations at the GXXXG motif (T402L/ G406L/G410L and T402R/G406L/G410L) followed by stable transfections in HEK 293 cells.
X
ABCG2 p.Thr402Arg 20088606:92:132
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:92:265
status: VERIFIED
Login to comment

94 We expected the T402R substitution to be a more drastic substitution on the basis of the change in both size and polarity.
X
ABCG2 p.Thr402Arg 20088606:94:16
status: VERIFIED
Login to comment

101 The T402L and T402R mutants exhibited levels comparable to the control (R482G), while the double (G406L/G410L) and triple mutants (T402L/G406L/G410L and T402R/G406L/G410L) had significantly decreased levels.
X
ABCG2 p.Thr402Arg 20088606:101:14
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:101:153
status: VERIFIED
Login to comment

103 In the case of T402R/G406L/G410L, the lower band comprised the majority of the detected protein.
X
ABCG2 p.Thr402Arg 20088606:103:15
status: VERIFIED
Login to comment

106 As shown in the first column of Figure 1B, the control (R482G) and the T402L and T402R mutants displayed similar levels of surface expression.
X
ABCG2 p.Thr402Arg 20088606:106:81
status: VERIFIED
Login to comment

108 In the T402R/G406L/G410L triple mutant, only a slight shift between the negative control(solid line) and the 5D3-labeled histograms (dashed line) was present.
X
ABCG2 p.Thr402Arg 20088606:108:7
status: VERIFIED
Login to comment

122 As expected, no change in molecular mass was observed in the control, T402L, or T402R after Endo H digestion (Figure 2A), since Endo H resistance is consistent with a fully mature glycoprotein.
X
ABCG2 p.Thr402Arg 20088606:122:80
status: VERIFIED
Login to comment

130 (A) Cell lysates from stably transfected HEK 293 cells (20 μg for R482G, T402L, and T402R and 60 μg for G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L) were separated via SDS-PAGE, transferred onto a PVDF membrane, and probed with monoclonal anti-ABCG2 antibody BXP-21.
X
ABCG2 p.Thr402Arg 20088606:130:90
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:130:152
status: VERIFIED
Login to comment

135 On the other hand, the protein level of the control, T402R, and T402L proteins increased more than 2-fold when cells were treated with bafilomycin, consistent with a previous report that fully processed ABCG2 undergoes lysosomal degradation as part of the protein turnover (33).
X
ABCG2 p.Thr402Arg 20088606:135:53
status: VERIFIED
Login to comment

136 In contrast, the protein levels of the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/ G410L mutants were little affected by bafilomycin treatment (Figure 3).
X
ABCG2 p.Thr402Arg 20088606:136:75
status: VERIFIED
Login to comment

142 In the case of the control, T402L, and T402R proteins, no significant differences between the MX-treated and untreated samples were observed (Figure 4A).
X
ABCG2 p.Thr402Arg 20088606:142:39
status: VERIFIED
Login to comment

145 The average percent of mutant protein detected in the lower and upper bands with and without MX is presented in Figure 4B. Notably, the results obtained with the arginine triple mutant (T402R/G406L/G410L) revealed little shift of the lower band, consistent with a more profound defect.
X
ABCG2 p.Thr402Arg 20088606:145:186
status: VERIFIED
Login to comment

147 No change was observed in the mainly plasma membrane staining for the control, T402L, and T402R proteins after treatment with MX by confocal microscopy (Figure 5).
X
ABCG2 p.Thr402Arg 20088606:147:90
status: VERIFIED
Login to comment

149 In contrast, after treatment with MX, the T402R/G406L/G410L mutant still primarily displayed intracellular localization.
X
ABCG2 p.Thr402Arg 20088606:149:42
status: VERIFIED
Login to comment

152 In contrast, the lower-molecular mass form of the T402R/G406L/G410L mutant, which did not shift to the upper 72 kDa band in the presence of MX, was still sensitive to digestion with Endo H (Figure 6B).
X
ABCG2 p.Thr402Arg 20088606:152:50
status: VERIFIED
Login to comment

155 Immunoblot analysis of cell lysates from the R482G, T402L, and T402R mutants [(A) 35 μg] and from the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L mutants [(B) 70 μg] with the BXP-21 antibody following overnight treatment with Endo H or N-glycosidase F.
X
ABCG2 p.Thr402Arg 20088606:155:63
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:155:144
status: VERIFIED
Login to comment

158 Cells were harvested after overnight incubation with or without 10 nM bafilomycin followed by immunoblot analysis with the BXP-21 and GAPDH antibodies for the R482G, T402L, and T402R mutants (40 μg/lane) and the G406L/G410L, T402L/G406L/G410L, and T402R/G406L/G410L mutants (100 μg/lane).
X
ABCG2 p.Thr402Arg 20088606:158:177
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:158:254
status: VERIFIED
Login to comment

166 (A) Following overnight incubation with or without 5 μM MX, cells were harvested, and the lysates (25 μg for R482G, T402R, and T402L and 50 μg for the other mutants) were subjected to immunoblot analysis with the BXP-21 and GAPDH antibodies as described in the legend of Figure 1.
X
ABCG2 p.Thr402Arg 20088606:166:128
status: VERIFIED
Login to comment

170 Figure 7 demonstrates increased molecular mass bands consistent with cross-linking of the control, T402R, and T402R/ G406L/G410L proteins.
X
ABCG2 p.Thr402Arg 20088606:170:99
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:170:110
status: VERIFIED
Login to comment

178 To evaluate the extended TXXXGXXXG motif in ABCG2, we substituted threonine 402 with arginine, since it had a greater impact on the protein relative to leucine (as suggested by the differences observed in localization and ability to be rescued by MX).
X
ABCG2 p.Thr402Arg 20088606:178:66
status: VERIFIED
Login to comment

179 Figure 8B shows that the TM carrying the T402R mutation had CAT activity comparable to that of wild-type ABCG2 TM1.
X
ABCG2 p.Thr402Arg 20088606:179:41
status: VERIFIED
Login to comment

180 In contrast, G406L/G410L and T402R/G406L/G410L demonstrated an approximately 50% or more decrease in their CAT activity, implying impaired dimerization of these mutant TMs.
X
ABCG2 p.Thr402Arg 20088606:180:29
status: VERIFIED
Login to comment

196 After overnight incubation with or without 5 μM MX, cells were harvested, and the lysates were subjected to overnight digestion with Endo H followed by immunoblot analysis with the BXP-21 antibody [(A) 35 μg for R482G, T402R, and T402L and (B) 70 μg for the double and triple mutants].
X
ABCG2 p.Thr402Arg 20088606:196:231
status: VERIFIED
Login to comment

199 Cross-linking is observed in the control, T402L, T402R, and the triple mutants as suggested by higher-molecular mass species.
X
ABCG2 p.Thr402Arg 20088606:199:49
status: VERIFIED
Login to comment

204 Following incubation with the ABCG2 substrate, MX, T402L/T406L/T410L readily shifted to the plasma membrane while T402R/T406L/T410L did not.
X
ABCG2 p.Thr402Arg 20088606:204:114
status: VERIFIED
Login to comment

226 (B) CAT activity measured in the TOXCAT assay for the G406L/G410L, T402R, and T402R/G406L/G410L mutants compared to that of wild-type TM1 of ABCG2.
X
ABCG2 p.Thr402Arg 20088606:226:67
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:226:78
status: VERIFIED
Login to comment

229 Although the substitution with the larger positively charged arginine was expected to be an unfavorable change in the membrane environment and likely to disrupt the association of the transmembrane helices, the T402R mutant appeared on the cell surface and is capable of efflux.
X
ABCG2 p.Thr402Arg 20088606:229:211
status: VERIFIED
Login to comment

233 Our results with the ABCG2 triple mutants carrying the threonine 402 to leucine or arginine substitutions (T402R/ G406L/G410L and T402R/G406L/G410L) are consistent with destabilization of the homodimer.
X
ABCG2 p.Thr402Arg 20088606:233:55
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:233:107
status: VERIFIED
X
ABCG2 p.Thr402Arg 20088606:233:130
status: VERIFIED
Login to comment

245 (E) Close-up view of the T402R mutation.
X
ABCG2 p.Thr402Arg 20088606:245:25
status: VERIFIED
Login to comment

258 In contrast, the T402R/G406L/G410L mutant, carrying the more drastic substitution at residue 402, did not show the same phenomenon (Figures 4-6).
X
ABCG2 p.Thr402Arg 20088606:258:17
status: VERIFIED
Login to comment

PMID: 20739628 [PubMed] Ni Z et al: "Transmembrane helices 1 and 6 of the human breast cancer resistance protein (BCRP/ABCG2): identification of polar residues important for drug transport."
No. Sentence Comment
11 While T402A and T402R showed a significant global reduction in the efflux of mitoxantrone, Hoechst 33342, and BODIPY-prazosin, N629A exhibited significantly increased efflux activities for all of the substrates.
X
ABCG2 p.Thr402Arg 20739628:11:16
status: VERIFIED
Login to comment

82 Generation of Flp-In-293 cells stably expressing wild-type BCRP and the mutants T402A and T402R.
X
ABCG2 p.Thr402Arg 20739628:82:90
status: VERIFIED
Login to comment

85 The resulting pcDNA5/FRT/BCRP plasmid containing full-length human BCRP cDNA was used as a template to generate T402A and T402R, as described above.
X
ABCG2 p.Thr402Arg 20739628:85:122
status: VERIFIED
Login to comment

86 The forward primer used to generate T402R was 5=-GCT CAG ATC ATT GTC AGA GTC GTA CTG GGA CTG-3=.
X
ABCG2 p.Thr402Arg 20739628:86:36
status: VERIFIED
Login to comment

88 One microgram of the pcDNA5/ FRT plasmid containing wild-type BCRP, T402A, or T402R cDNA or the empty vector were used to transfect Flp-In-293 cells, in combination with 2 ␮g of pOG44 using the FuGENE HD transfection reagent, according to the manufacturer`s instruction.
X
ABCG2 p.Thr402Arg 20739628:88:78
status: VERIFIED
Login to comment

90 The cells expressing wild-type BCRP, T402A, or T402R were then maintained in complete MEM medium containing 10% FBS, L-glutamine, and 125 ␮g/ml of hygromycin for subsequent experiments.
X
ABCG2 p.Thr402Arg 20739628:90:47
status: VERIFIED
Login to comment

255 Efflux activities of the mutants T402A and T402R expressed in Flp-In-293 cells.
X
ABCG2 p.Thr402Arg 20739628:255:43
status: VERIFIED
Login to comment

257 To investigate whether the decreased efflux activity of T402A was caused by altered pattern of oligomerization resulting from the higher level of protein expression that could subsequently affect BCRP activity, we generated Flp-In-293 cells stably expressing wild-type BCRP, T402A, or T402R.
X
ABCG2 p.Thr402Arg 20739628:257:285
status: VERIFIED
Login to comment

258 T402R was also analyzed, because a recent study revealed that this mutant could possibly affect BCRP activity (19).
X
ABCG2 p.Thr402Arg 20739628:258:0
status: VERIFIED
Login to comment

261 Indeed, as shown in Fig. 6A, wild-type BCRP, T402A, and T402R were expressed at comparable protein levels.
X
ABCG2 p.Thr402Arg 20739628:261:56
status: VERIFIED
Login to comment

262 Immunofluorescent confocal microscopy analysis indicated that T402A and T402R were predominantly localized on the plasma membrane of Flp-In-293 cells as was wild-type BCRP (Fig. 6B).
X
ABCG2 p.Thr402Arg 20739628:262:72
status: VERIFIED
Login to comment

264 Likewise, T402R also exhibited significantly lower activities compared with wild-type BCRP.
X
ABCG2 p.Thr402Arg 20739628:264:10
status: VERIFIED
Login to comment

265 Interestingly, efflux activities of T402R were further decreased compared with T402A, suggesting that Arg substitution of Thr402 caused a greater effect on BCRP function than Ala substitution, possibly due to more drastic changes in both size and polarity at position 402.
X
ABCG2 p.Thr402Arg 20739628:265:36
status: VERIFIED
X
ABCG2 p.Thr402Arg 20739628:265:102
status: VERIFIED
Login to comment

287 Two mutants of Thr402 , T402L and T402R, were generated in that study.
X
ABCG2 p.Thr402Arg 20739628:287:34
status: VERIFIED
Login to comment

289 For example, a particularly strong reduction in efflux of BODIPY-prazosin was associated with T402R.
X
ABCG2 p.Thr402Arg 20739628:289:94
status: VERIFIED
Login to comment

290 We verified that T402A and T402R, which were expressed in Flp-In-293 cells at comparable protein levels to wild-type BCRP, also exhibited significantly decreased efflux activities (Fig. 6).
X
ABCG2 p.Thr402Arg 20739628:290:27
status: VERIFIED
Login to comment

300 Expression and efflux activities of T402A and T402R in Flp-In-293 cells.
X
ABCG2 p.Thr402Arg 20739628:300:46
status: VERIFIED
Login to comment

301 A: representative immunoblot of whole cell lysates for wild-type BCRP and its mutants T402A and T402R expressed in Flp-In-293 cells.
X
ABCG2 p.Thr402Arg 20739628:301:96
status: VERIFIED
Login to comment

303 B: confocal microscopy analysis of Flp-In-293 cells expressing wild-type BCRP and its mutants T402A and T402R.
X
ABCG2 p.Thr402Arg 20739628:303:104
status: VERIFIED
Login to comment

305 C: fumitremorgin C (FTC)-inhibitable efflux activities of Flp-In-293 cells expressing wild-type BCRP and its mutants T402A and T402R for mitoxantrone, BODIPY-prazosin, and Hoechst 33342.
X
ABCG2 p.Thr402Arg 20739628:305:127
status: VERIFIED
Login to comment

PMID: 24021215 [PubMed] Stacy AE et al: "Molecular pharmacology of ABCG2 and its role in chemoresistance."
No. Sentence Comment
73 Mutational analysis of Thr402, which is located near the GXXXG motif (TXXGXXXG), in combination with mutations of the GXXXG motif (T402L or T402R and G406L or G410L; Fig. 3) resulted in a reduction in protein expression and drug efflux, alterations in glycosylation, and retention of ABCG2 in the ER (Polgar et al., 2010).
X
ABCG2 p.Thr402Arg 24021215:73:140
status: NEW
Login to comment

PMID: 25236865 [PubMed] Mao Q et al: "Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport--an update."
No. Sentence Comment
183 Ala or Arg substitution of Thr402 caused a significant reduction by 50-90% in efflux of mitoxantrone, BODIPY-prazosin, and Hoechst33342 as well as its ability to confer resistance to mitoxantrone and SN-38 (92).
X
ABCG2 p.Thr402Arg 25236865:183:7
status: NEW
Login to comment